Clinical Trial

GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy

Name: GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy — clinical trial record (NCT06636123)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this clinical trial is to determine if GZ17-6.02 delays progression of castration-resistant prostate cancer.

Protocol Amendment History 5 amendments

This ClinicalTrials.gov record has been amended 5 times since 2024-10-08; most recent amendment 2026-01-23.

Status change: Not Yet Recruiting → Recruiting 2025-02-20

Trial Details

NCT Number	NCT06636123
Lead Sponsor	Virginia Commonwealth University
Conditions	Castration-resistant Prostate Cancer
Enrollment	30 participants
Start Date	2025-02-18
Primary Completion	2027-04-30 (estimated)
Study Completion	2031-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-27